Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IMGN - ImmunoGen, Inc.


Close
31.23
0   0%

Share volume: 0
Last Updated: Fri 09 Feb 2024 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing : 2.72%

PREVIOUS CLOSE
CHG
CHG%

$31.23
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Report Date 2022-05-06 2022-08-01 2022-11-04 2023-03-01 2023-04-28 2023-07-31 2023-11-02
Total revenue 38.078 M 14.162 M 15.375 M 41.167 M 49.869 M 83.153 M 113.425 M
Cost of revenue 0.000 0.000 0.000 176.000 K 626.000 K 909.000 K 2.155 M
Gross profit 38.078 M 14.162 M 15.375 M 40.991 M 49.243 M 82.244 M 111.270 M
    -62.81% 8.57% 166.61% 20.13% 67.02% 35.29%  
Operating expenses 60.930 M 75.215 M 92.804 M 100.550 M 91.636 M 86.433 M 85.314 M
Selling general and admin 16.648 M 23.793 M 33.623 M 42.065 M 40.016 M 36.356 M 37.744 M
Research and development 44.282 M 51.422 M 59.181 M 58.485 M 51.620 M 50.077 M 47.570 M
Total expenses 60.930 M 75.215 M 92.804 M 100.726 M 92.262 M 87.342 M 87.469 M
    23.44% 23.38% 8.54% -8.40% -5.33% 0.15%  
Operating income -22.852 M -61.053 M -77.429 M -59.559 M -42.393 M -4.189 M 25.956 M
Ebit -22.852 M -61.053 M -77.429 M -59.559 M -42.393 M -4.189 M 25.956 M
Pretax income -24.145 M -62.021 M -77.755 M -57.790 M -41.014 M -3.371 M 29.582 M
    156.87% 25.37% -25.68% -29.03% -91.78% -977.54%  
Income tax 0.000 0.000 0.000 1.218 M 0.000 877.000 K -1.166 M
Net income basic -24.145 M -62.021 M -77.755 M -59.008 M -41.014 M -4.248 M 30.748 M
    -156.87% -25.37% 24.11% 30.49% 89.64% 823.82%  
Net income -24.145 M -62.021 M -77.755 M -59.008 M -41.014 M -4.248 M 30.748 M
    -156.87% -25.37% 24.11% 30.49% 89.64% 823.82%